NL7920190A - 24,24-difluor-1 alfa, 25-dihydroxycholecalciferol. - Google Patents

24,24-difluor-1 alfa, 25-dihydroxycholecalciferol. Download PDF

Info

Publication number
NL7920190A
NL7920190A NL7920190A NL7920190A NL7920190A NL 7920190 A NL7920190 A NL 7920190A NL 7920190 A NL7920190 A NL 7920190A NL 7920190 A NL7920190 A NL 7920190A NL 7920190 A NL7920190 A NL 7920190A
Authority
NL
Netherlands
Prior art keywords
vitamin
difluoro
formula
dihydroxy
ether
Prior art date
Application number
NL7920190A
Other languages
English (en)
Dutch (nl)
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NL7920190A publication Critical patent/NL7920190A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL7920190A 1979-03-28 1979-10-15 24,24-difluor-1 alfa, 25-dihydroxycholecalciferol. NL7920190A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2484879 1979-03-28
US06/024,848 US4201881A (en) 1979-03-28 1979-03-28 24,24-Difluoro-1α,25-dihydroxycholecalciferol

Publications (1)

Publication Number Publication Date
NL7920190A true NL7920190A (nl) 1981-01-30

Family

ID=21822707

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7920190A NL7920190A (nl) 1979-03-28 1979-10-15 24,24-difluor-1 alfa, 25-dihydroxycholecalciferol.

Country Status (15)

Country Link
US (1) US4201881A (xx)
JP (2) JPS6342618B2 (xx)
AU (1) AU530015B2 (xx)
BE (1) BE882143A (xx)
CH (1) CH650240A5 (xx)
DK (1) DK147300C (xx)
FR (1) FR2452481A1 (xx)
GB (2) GB2067567B (xx)
IE (1) IE49753B1 (xx)
IL (1) IL58526A (xx)
IT (1) IT1140776B (xx)
NL (1) NL7920190A (xx)
NZ (1) NZ191900A (xx)
SE (1) SE8008339L (xx)
WO (1) WO1980002028A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
NZ201702A (en) * 1981-08-28 1985-08-16 Hoffmann La Roche 1 alpha,25-dihydroxy-(24r or 24s)-fluorocholecal-ciferol and intermediates;pharmaceutical compositions
EP0094644B1 (de) * 1982-05-17 1986-07-30 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verwendung eines Cholecalciferolderivates
US4456689A (en) * 1982-05-17 1984-06-26 Becton Dickinson And Company Competitive protein binding assay using an organosilane-silica gel separation medium
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
JPS6253960A (ja) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd ビタミンd↓3の誘導体
US4832875A (en) * 1985-11-21 1989-05-23 Taisho Pharmaceutical Co., Ltd. Vitamin D3 derivative
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
JP2011508743A (ja) * 2007-12-28 2011-03-17 ウィスコンシン アラムナイ リサーチ ファンデーション (20s)−23,23−ジフルオロ−2−メチレン−19−ノル−ビスホモプレグナカルシフェロール−ビタミンd類縁体
JP5504898B2 (ja) 2010-01-08 2014-05-28 セントラル硝子株式会社 ジフルオロシクロプロパン化合物の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741996A (en) * 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3969700A (en) * 1974-04-10 1976-07-13 International Business Machines Corporation Regional context maximum likelihood error correction for OCR, keyboard, and the like
FR2267590B1 (xx) * 1974-04-10 1977-05-20 Ibm
JPS5729745B2 (xx) * 1974-09-25 1982-06-24
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same

Also Published As

Publication number Publication date
GB2045765B (en) 1983-06-15
FR2452481B1 (xx) 1984-10-19
IE49753B1 (en) 1985-12-11
JPS63179855A (ja) 1988-07-23
IT8020508A0 (it) 1980-03-11
WO1980002028A1 (en) 1980-10-02
US4201881A (en) 1980-05-06
NZ191900A (en) 1984-11-09
BE882143A (fr) 1980-07-01
DK505080A (da) 1980-11-27
IT1140776B (it) 1986-10-10
JPS56500296A (xx) 1981-03-12
IL58526A0 (en) 1980-01-31
GB2045765A (en) 1980-11-05
GB2067567A (en) 1981-07-30
CH650240A5 (de) 1985-07-15
AU530015B2 (en) 1983-06-30
IE800619L (en) 1980-09-28
JPS6342618B2 (xx) 1988-08-24
IL58526A (en) 1983-05-15
SE8008339L (sv) 1980-11-27
JPH0146504B2 (xx) 1989-10-09
GB2067567B (en) 1983-03-02
DK147300B (da) 1984-06-12
FR2452481A1 (fr) 1980-10-24
AU5581080A (en) 1980-10-02
DK147300C (da) 1984-12-24

Similar Documents

Publication Publication Date Title
US5552392A (en) Method of treating hypoparathyroidism with (20S) vitamin D compounds
US4689180A (en) 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
US4188345A (en) Fluorovitamin D compounds and processes for their preparation
US4226788A (en) 24,24-Difluoro-1α,25-dihydroxycholecalciferol
NL7920190A (nl) 24,24-difluor-1 alfa, 25-dihydroxycholecalciferol.
WO1983000335A1 (en) 26,26,26,27,27,27-HEXAFLUORO-1'alpha',25-DIHYDROXYCHOLECALCIFEROL AND PROCESS FOR PREPARING SAME
EP1745787A2 (en) Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3
IE50815B1 (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPH02288829A (ja) 骨の損耗の予防又は再生不調症の治療又は予防用薬剤
NL8420327A (nl) Isomeren van hydroxyvitamine d2.
Higashi et al. Characterization of new conjugated metabolites in bile of rats administered 24, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3
US4196133A (en) 24,24-Difluoro-25-hydroxycholecalciferol
US4224231A (en) Derivatives of 25-hydroxycholecalciferol
IE67953B1 (en) Side Chain Unsaturated 1alpha-Hydroxyvitamin D Homologs
US5354744A (en) Side chain unsaturated 1 alpha-hydroxyvitamin D analogs
AU587174B2 (en) 1a, 25-dihydroxy-22z-dehydrovitamin d compound
US4229358A (en) Fluorovitamin D compounds and processes for their preparation
US4263214A (en) Fluorovitamin D compounds and processes for their preparation
DE3590080C2 (xx)
US4226787A (en) Fluorovitamin D compounds and processes for their preparation
US4224230A (en) Fluorovitamin D compounds and processes for their preparation
US4229357A (en) Fluorovitamin D compounds and processes for their preparation
NZ207413A (en) Steroid intermediates in the preparation of 24,24-difluoro-25-hydroxy-vitamin d3
US4230627A (en) Fluorovitamin D compounds and processes for their preparation
FR2550789A1 (fr) 23,23-difluoro-25-hydroxy- et 1a,25-dihydroxy-vitamine d3